News

• Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
  02/28/2022 / 13:30 - GlobeNewswire
•  
• Mainz Biomed Appoints Oncology Expert Dr. Rainer Metzger to Strategic Advisory Board
  02/09/2022 / 09:01 - GlobeNewswire
•  
• DAX to be expanded by 10 companies on Monday
  09/17/2021 / 16:30 - TeleTrader
•  
• Ten new companies to join DAX on September 20
  09/03/2021 / 22:35 - TeleTrader
•  
• FDA approves QIAGEN rapid COVID testing
  08/06/2021 / 21:01 - TeleTrader
•  
• Oncocyte Selected as New “Day One” Launch Site for QIAGEN’s Companion Diagnostics Test to Identify Patients for Amgen’s Newly FDA-Approved Drug LUMAKRAS (Sotorasib) For Advanced Stage Lung Cancer
  06/01/2021 / 14:00 - GlobeNewswire
•  
• Ellume Establishes Flagship U.S. Manufacturing Facility in Maryland
  05/10/2021 / 16:00 - GlobeNewswire
•  
• Abcam and MEDx extend precision medicine strategic partnership
  04/12/2021 / 11:00 - GlobeNewswire
•  
• OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
  12/09/2020 / 13:30 - GlobeNewswire
•  
• HTG Molecular Diagnostics Reports Third Quarter 2020 Results
  11/10/2020 / 22:01 - GlobeNewswire
•  
• Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
  10/06/2020 / 21:30 - GlobeNewswire
•  
• Thermo Fisher's acquisition of Qiagen fails
  08/13/2020 / 13:48 - TeleTrader
•  
• HTG Molecular Diagnostics Reports Second Quarter 2020 Results
  08/11/2020 / 22:01 - GlobeNewswire
•  
• OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
  08/11/2020 / 13:30 - GlobeNewswire
•  
• HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN
  08/10/2020 / 22:01 - GlobeNewswire